SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-197849
Filing Date
2020-07-23
Accepted
2020-07-23 17:01:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d44116ds3.htm S-3 266933
2 EX-4.5 d44116dex45.htm EX-4.5 310401
3 EX-5.1 d44116dex51.htm EX-5.1 30375
4 EX-23.1 d44116dex231.htm EX-23.1 1562
5 GRAPHIC g44116cov.jpg GRAPHIC 10011
6 GRAPHIC g44116ex5_1.jpg GRAPHIC 2363
  Complete submission text file 0001193125-20-197849.txt   627823
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-240052 | Film No.: 201044198
SIC: 2834 Pharmaceutical Preparations